https://sjiasupersquad.com/external-post/development-of-a-screening-algorithm-for-lung-disease-in-systemic-juvenile-idiopathic-arthritis/2023-11-13T18:34:01+00:00https://sjiasupersquad.com/external-post/ronnys-story-fighting-insurance-delays-to-keep-my-child-healthy/2023-11-13T18:44:29+00:00https://sjiasupersquad.com/external-post/interferon-blocker-crushes-macrophage-activation-syndrome/2023-11-21T23:48:38+00:00https://sjiasupersquad.com/external-post/online-survey-of-covid-19-immunization-and-infection-in-patients-with-systemic-juvenile-idiopathic-arthritis-and-adult-onset-stills-disease/2023-11-22T12:50:14+00:00https://sjiasupersquad.com/external-post/281/2024-01-11T00:49:31+00:00https://sjiasupersquad.com/external-post/the-use-of-ruxolitinib-for-improved-disease-control-in-systemic-juvenile-idiopathic-arthritis-sjia-and-recurrent-macrophage-activation-syndrome-mas/2024-01-11T00:51:08+00:00https://sjiasupersquad.com/external-post/type-i-interferon-signature-and-cycling-lymphocytes-in-macrophage-activation-syndrome/2024-02-05T13:10:50+00:00https://sjiasupersquad.com/external-post/interleukinil-1-il-6-inhibitor-associated-drug-reaction-with-eosinophilia-and-systemic-symptoms-dress-in-systemic-inflammatory-illnesses/2024-07-16T22:52:42+00:00https://sjiasupersquad.com/external-post/novel-drug-works-near-miracle-for-sjia-patients-with-life-threatening-complication/2024-08-28T16:46:37+00:00https://sjiasupersquad.com/external-post/serum-interleukin-18-levels-can-improve-the-diagnostic-performance-of-the-printo-and-ilar-criteria-for-systemic-juvenile-idiopathic-arthritis/2024-10-12T10:54:41+00:00https://sjiasupersquad.com/external-post/daughters-arthritis-drives-family-to-action/2024-10-25T23:57:14+00:00https://sjiasupersquad.com/external-post/new-recommendations-developed-to-unify-sjia-and-aosd/2024-10-30T22:52:10+00:00https://sjiasupersquad.com/external-post/characterization-of-genetic-landscape-and-novel-inflammatory-biomarkers-in-patients-with-adult-onset-stills-disease/2024-11-12T18:34:34+00:00https://sjiasupersquad.com/external-post/clinical-characteristics-and-prognosis-of-interstitial-lung-disease-in-systemic-juvenile-idiopathic-arthritis-a-two-center-retrospective-observational-cohort-study/2024-11-12T23:08:35+00:00https://sjiasupersquad.com/external-post/the-place-of-jak-inhibitors-in-systemic-juvenile-idiopathic-arthritis-with-lung-disease-sjia-ld-french-experience/2024-11-12T23:12:18+00:00https://sjiasupersquad.com/external-post/interleukin-il-1-il-6-inhibitor-associated-drug-reaction-with-eosinophilia-and-systemic-symptoms-dress-in-systemic-inflammatory-illnesses/2024-11-14T17:15:25+00:00https://sjiasupersquad.com/external-post/efficacy-and-safety-of-tofacitinib-in-patients-with-active-systemic-juvenile-idiopathic-arthritis/2024-11-19T23:38:53+00:00https://sjiasupersquad.com/external-post/pif-partners-granted-fda-rare-pediatric-disease-designation-for-its-proprietary-small-molecule-in-treating-systemic-juvenile-idiopathic-arthritis-sjia-flares/2024-12-04T22:55:10+00:00https://sjiasupersquad.com/external-post/could-biomarkers-help-to-detect-lung-disease-earlier-in-systemic-jia/2024-12-13T13:50:51+00:00https://sjiasupersquad.com/external-post/allogeneic-haematopoietic-stem-cell-transplantation-for-children-with-refractory-systemic-juvenile-idiopathic-arthritis-and-associated-lung-disease-outcomes-from-an-international-retrospective-cohor/2024-12-31T22:07:49+00:00https://sjiasupersquad.com/external-post/eular-recommends-unifying-sjia-and-aosd/2025-01-29T12:46:51+00:00https://sjiasupersquad.com/external-post/u-s-fda-approves-celltrions-avtozma-tocilizumab-anoh-a-biosimilar-to-actemra/2025-01-31T22:02:59+00:00https://sjiasupersquad.com/external-post/systemic-juvenile-idiopathic-arthritis-market-size-to-reach-usd-1250-million-by-2035-impelled-by-advancements-in-biologic-therapies/2025-02-15T22:21:06+00:00https://sjiasupersquad.com/external-post/brucella-bloodstream-infection-mimicking-systemic-juvenile-idiopathic-arthritis-a-pediatric-case-report/2025-02-23T13:25:22+00:00https://sjiasupersquad.com/external-post/frost-study-gives-real-world-insights-into-systemic-jia-treatment-outcomes/2025-04-26T20:54:36+00:00https://sjiasupersquad.com/external-post/elevated-serum-levels-of-interleukin-18-discriminate-stills-disease-from-other-autoinflammatory-conditions-results-from-the-european-immunaid-cohort/2025-06-11T23:30:20+00:00https://sjiasupersquad.com/external-post/albumin-and-gamma-glutamyl-transferase-as-biomarkers-for-differentiating-systemic-juvenile-idiopathic-arthritis-from-reactive-arthritis/2025-06-13T10:42:18+00:00https://sjiasupersquad.com/external-post/fda-approves-gamifant-for-stills-disease/2025-06-28T21:57:37+00:00https://sjiasupersquad.com/external-post/giant-cell-arteritis-market-heats-up-with-abbvies-rinvoq-approval-delveinsight/2025-07-03T12:01:51+00:00https://sjiasupersquad.com/external-post/single-cell-transcriptomes-of-immune-cells-offer-insight-into-juvenile-idiopathic/2025-07-03T12:04:03+00:00https://sjiasupersquad.com/external-post/ube2d1-as-a-key-biomarker-in-systemic-juvenile-idiopathic-arthritis-a-new-perspective-on-diagnosis-and-disease-activity-assessment/2025-07-12T18:34:30+00:00https://sjiasupersquad.com/external-post/associations-of-lymphocyte-subpopulations-related-cytokines-clinical-phenotypes-and-outcomes-in-systemic-juvenile-idiopathic-arthritis/2025-07-30T22:08:33+00:00https://sjiasupersquad.com/external-post/breastfeeding-duration-and-the-risk-of-systemic-juvenile-idiopathic-arthritis-a-cross-sectional-study/2025-08-20T22:57:13+00:00https://sjiasupersquad.com/external-post/eli-lillys-pediatric-arthritis-study-a-potential-game-changer/2025-08-27T13:56:29+00:00https://sjiasupersquad.com/external-post/serum-ferritin-levels-serve-as-biomarker-of-disease-activity-in-juvenile-idiopathic-arthritis/2025-09-05T12:39:06+00:00https://sjiasupersquad.com/external-post/long-term-safety-of-canakinumab-in-patients-with-systemic-juvenile-idiopathic-arthritis-5-year-results-from-the-childhood-arthritis-and-rheumatology-research-alliance-carra-registry/2025-11-03T18:16:46+00:00https://sjiasupersquad.com/external-post/biomarker-guided-treatment-and-stop-strategy-for-recombinant-il-1receptor-antagonist-anakinra-in-patients-with-systemic-juvenile-idiopathic-arthritis/2025-11-18T23:07:29+00:00https://sjiasupersquad.com/external-post/interleukin-18-levels-are-associated-with-disease-course-in-patients-with-stills-disease-treated-with-il-1-inhibitors/2026-01-04T12:11:39+00:00https://sjiasupersquad.com/external-post/type-i-interferon-signature-associates-with-lung-disease-drug-associated-immune-reactions-and-genetic-variation-in-interferon-linked-pathways-in-stills-disease/2026-02-20T12:54:24+00:00https://sjiasupersquad.com/external-post/mtorc1-links-pathology-in-experimental-models-of-stills-disease-and-macrophage-activation-syndrome/2026-02-20T12:57:58+00:00https://sjiasupersquad.com/external-post/reliability-and-construct-validity-of-the-physicians-global-assessment-of-lung-disease-in-systemic-juvenile-idiopathic-arthritis-associated-lung-disease/2026-03-31T14:26:34+00:00https://sjiasupersquad.com/external-post/single-cell-study-reveals-immune-issues-in-juvenile-arthritis/2026-06-10T00:26:03+00:00https://sjiasupersquad.com/external-post/ab2-bio-receives-30-million-from-nippon-shinyaku-for-exclusive-u-s-commercialization-rights-to-tadekinig-alfa/2026-07-30T18:26:33+00:00